Cancer

Fate Therapeutics to Present at 2024 Cantor Global Healthcare Conference

Retrieved on: 
Thursday, September 12, 2024
IPSC, Conference, Cancer, SAN, Therapy, Patient

SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that the Company will present at the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024 at 12:45 PM ET in New York, New York.

Key Points: 
  • SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that the Company will present at the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024 at 12:45 PM ET in New York, New York.
  • A live webcast, if recorded, of the presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.fatetherapeutics.com .
  • The archived webcast will be available on the Company’s website shortly after the event.

Immunocore to present at the 2024 Cantor Global Healthcare Conference

Retrieved on: 
Thursday, September 12, 2024
Conference, Infection, Cancer, Patient

(OXFORDSHIRE, England & CONSHOHOCKEN, Penn.

Key Points: 
  • (OXFORDSHIRE, England & CONSHOHOCKEN, Penn.
  • & ROCKVILLE, Md., US, 12 September 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”) , a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that management will participate in the 2024 Cantor Global Healthcare Conference.
  • The presentation will be webcast live and can be accessed by visiting ‘Events & Presentations’, under ‘Events’, via the ‘Investors’ section of Immunocore’s website at www.immunocore.com.
  • Following the event, a replay of the presentation will be made available for a limited time.

Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Thursday, September 12, 2024
Professional Services, Oncology, Health, Finance, Pharmaceutical, Biotechnology, File, Research, Security (finance), State Street, Attention, Capital market, Brookfield Place, Prospectus, Exercise, Cancer, Vesey Street, Equity capital markets, Public expenditure, RBC Capital Markets, Sale, Syndicate, RBC, SVB Securities, Form, Telephone

The pre-funded warrants are immediately exercisable and have an exercise price of $0.01 per share.

Key Points: 
  • The pre-funded warrants are immediately exercisable and have an exercise price of $0.01 per share.
  • The gross proceeds to Xencor from this offering were approximately $201.3 million, before deducting underwriting discounts and commissions and offering expenses.
  • Leerink Partners, Raymond James and RBC Capital Markets acted as joint book-running managers for the offering.
  • The public offering was made pursuant to an automatic shelf registration statement on Form S-3 (File No.

The Boiling Crab® Partners With The National Pediatric Cancer Foundation® (NPCF) and RIF LA In Support of Childhood Cancer Awareness Month

Retrieved on: 
Thursday, September 12, 2024
Postmates, Research, Young Lives vs Cancer, Patient, Disease, Cancer, Human, Survivor, Boiling, Death, Good Kids, Clothing, Shoe, Partnership, Good People, Childhood cancer

LOS ANGELES, Sept. 12, 2024 /PRNewswire/ -- In honor of Childhood Cancer Awareness Month, The Boiling Crab®, renowned for its authentic Louisiana-style Cajun seafood boils, is excited to announce a new partnership with The National Pediatric Cancer Foundation® (NPCF) and RIF Los Angeles. From September 16 to October 13, 2024, The Boiling Crab will contribute a portion of the proceeds from all boiled shrimp and crawfish sales—whether in-store or through online orders via Postmates—to support the National Pediatric Cancer Foundation's mission to end childhood cancer.

Key Points: 
  • "We are thankful and proud to be partnering with The Boiling Crab to raise awareness and funds to support pediatric cancer research," said David Frazer, CEO of the National Pediatric Cancer Foundation.
  • "We are excited to partner with The Boiling Crab on a special shirt to raise awareness for Childhood Cancer Awareness Month.
  • Only 4% of the billions of dollars spent annually on cancer research is directed towards childhood cancer.
  • 89 cents of every dollar donated to the National Pediatric Cancer Foundation® goes directly to funding clinical trials for less toxic and more effective treatments for childhood cancer.

BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions

Retrieved on: 
Thursday, September 12, 2024
Chronic condition, Research, Patient, Regenerative medicine, Cancer, MOU, Quality of life, Health, Partnership, Risk, Medicine, Pharmaceutical industry

This partnership aims to expand the Company’s expertise and presence in cancer screening, precision medicine, and preventative healthcare through its subsidiary MRNA Scientific Sdn Bhd.

Key Points: 
  • This partnership aims to expand the Company’s expertise and presence in cancer screening, precision medicine, and preventative healthcare through its subsidiary MRNA Scientific Sdn Bhd.
  • The partnership between the Company and Shenzhen Rongguang Health Group represents a significant step forward in developing advanced healthcare technologies, with a focus on early cancer detection, personalized healthcare solutions, and broader preventative care.
  • The strategic partnership will allow both companies to leverage their expertise to address critical healthcare challenges and improve patient outcomes.
  • By joining forces with Shenzhen Rongguang Health Group, we are not only advancing our efforts in cancer screening but also expanding into the broader healthcare sector with cutting-edge solutions for preventative medicine and regenerative healthcare.

Truma North America Donates More than 100 Portable Fridge/Freezers to Care Camps Foundation

Retrieved on: 
Thursday, September 12, 2024
Hope, Food, Cancer, American Childhood Cancer Organization, AC

ELKHART, Ind., Sept. 12, 2024 /PRNewswire/ -- Truma North America is proud to announce a significant donation to Care Camps Foundation, elevating their mission to give joy, hope and the healing power of the outdoors to children with cancer and their families at medically supervised pediatric oncology camps.

Key Points: 
  • Truma North America, a premium supplier to the RV and outdoor recreation industry, is the newest partner to amplify Care Camp Foundation's mission, donating over 100 Truma Cooler portable refrigerators/freezers to camps across North America.
  • "Earlier this year we had the opportunity to hear Care Camps Foundation Executive Director Gwynn Sullivan speak," said Gerhard Hundsberger, President and CEO of Truma North America.
  • Truma worked with Care Camps Foundation and the Children's Oncology Camping Association (COCA) which oversees the quality assurance of each camp to identify those needing help with on-site refrigeration.
  • Gwynn Sullivan, Care Camps Foundation Executive Director says the donation and support from Truma is a testament to the power of creative partnerships.

EQS-News: Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange

Retrieved on: 
Thursday, September 12, 2024
Radiopharmaceutical, AG, USD, Research, University, NHL, Bone marrow, Patient, Annual general meeting, FDA, Supervisory board, Diagnosis, Primary aldosteronism, Cancer, Food, IPO, Hypertension, Frankfurt Stock Exchange, CXCR4, IIS, Regulated market, Radionuclide, AMERICA, Bookrunner, Patent, Pharmaceutical industry

Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange

Key Points: 
  • Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange
    The issuer is solely responsible for the content of this announcement.
  • While Eckert & Ziegler's core business revolves around the production and distribution of radioisotopes, Pentixapharm is dedicated to the development and approval of new radiopharmaceuticals.
  • The planned IPO enables Pentixapharm to target investors specifically interested in the company's innovative and forward-looking pipeline.
  • As an independent company, Pentixapharm can now operate more flexibly to advance its research and development projects.

NFL Alumni & Giants Great Victor Cruz Team Up To Celebrate Hispanic Heritage Month

Retrieved on: 
Thursday, September 12, 2024
Love, Prevalence, CDC, Obesity, Hope, Disease, Happiness, Heart, Health, Diabetes, Culture, NFLA, Social media, Giant, Family, Cancer, Birth control

From September 15 through October 15, New York Giants football great and Super Bowl Champion Victor Cruz, who is of Puerto Rican decent, will serve as program Ambassador.

Key Points: 
  • From September 15 through October 15, New York Giants football great and Super Bowl Champion Victor Cruz, who is of Puerto Rican decent, will serve as program Ambassador.
  • Locally, the New York Giants organization is lending a ‘Giant Blue’ hand in support of Hispanic Heritage Month by running themed videos in-stadium, sharing content during weekly programming and driving social media activity.
  • “Many in the Hispanic community may not be aware that living with a disease like obesity can impact the rest of your health,” says Giants alum Victor Cruz.
  • We’re honored to partake in Hispanic Heritage Month, a time of great celebration, love and family.

Immuno-Oncology Researchers Have Leveraged $200,000 in Seed Grant Funding from Curebound to Secure $9.6M in NIH Follow-On Funding and Launch Clinical Trial for Head and Neck Cancer Immunotherapy

Retrieved on: 
Thursday, September 12, 2024
Research, Clinical Trials, Professional Services, Philanthropy, Socially Responsible Investing, Health, Foundation, Science, Oncology, UC, Investment, University, UC San Diego Health, Patient, Bangladesh Technical Education Board, Hope, Disease, Nature Communications, Cancer, HNSCC, Radiation, Metformin, Immunotherapy, NIH, DRS, Lymph, Head, Oral cancer, HER3, Translation, IVA, Immune system, Pharmaceutical industry

While immunotherapies have revolutionized treatment for various types of cancers, most head and neck cancer patients have seen little benefit, with clinical responses often lacking durability.

Key Points: 
  • While immunotherapies have revolutionized treatment for various types of cancers, most head and neck cancer patients have seen little benefit, with clinical responses often lacking durability.
  • Preserving lymph nodes during treatment initiation helps the body's immune system fight head and neck cancer more effectively.
  • Targeting a specific protein called HER3 that can make immunotherapy work better in treating head and neck cancer.
  • “Our work could significantly impact head and neck cancer therapies, as well as other cancer treatments.

North America Aqueous Parts Washer Market Insights 2024-2029: Growing Inclination Towards Sustainability, Customizable And Modular Designs, Enhanced Safety Features - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 12, 2024
Machinery, Other Manufacturing, Manufacturing, Internet of things, Water, Engineering, Safety, Irritation, SBS, Organic compound, Automation, Electronics, Cancer, Health, Toxicity, Oil, Volatile organic compound, EPA, Temperature, Risk, Traction, Injury, CSR, Detergent, Carbon, Adsorption, Pressure, Consumer, Environmental remediation

The "North America Aqueous Parts Washer Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "North America Aqueous Parts Washer Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.
  • The competitive scenario in the North American aqueous parts washer market is intensifying, with domestic players offering diverse products.
  • What is the growth rate of the North America aqueous parts washer market?
  • What are the key drivers of the North America aqueous parts washer market?